annual CFF:
$809.89M+$755.57M(+1390.92%)Summary
- As of today (June 22, 2025), DYN annual cash flow from financing activities is $809.89 million, with the most recent change of +$755.57 million (+1390.92%) on December 31, 2024.
- During the last 3 years, DYN annual CFF has risen by +$652.07 million (+413.17%).
- DYN annual CFF is now at all-time high.
Performance
DYN Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$141.24M+$137.60M(+3784.52%)Summary
- As of today (June 22, 2025), DYN quarterly cash flow from financing activities is $141.24 million, with the most recent change of +$137.60 million (+3784.52%) on March 31, 2025.
- Over the past year, DYN quarterly CFF has dropped by -$267.15 million (-65.41%).
- DYN quarterly CFF is now -65.41% below its all-time high of $408.39 million, reached on March 31, 2024.
Performance
DYN quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$542.75M-$267.15M(-32.99%)Summary
- As of today (June 22, 2025), DYN TTM cash flow from financing activities is $542.75 million, with the most recent change of -$267.15 million (-32.99%) on March 31, 2025.
- Over the past year, DYN TTM CFF has increased by +$108.85 million (+25.09%).
- DYN TTM CFF is now -32.99% below its all-time high of $809.89 million, reached on December 31, 2024.
Performance
DYN TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
DYN Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1390.9% | -65.4% | +25.1% |
| 3 y3 years | +413.2% | +10000.0% | +10000.0% |
| 5 y5 years | +3951.7% | +1086.1% | +4457.8% |
DYN Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +2066.1% | -65.4% | >+9999.0% | -33.0% | >+9999.0% |
| 5 y | 5-year | at high | +3951.7% | -65.4% | +1361.8% | -33.0% | >+9999.0% |
| alltime | all time | at high | +6419.8% | -65.4% | +1361.8% | -33.0% | >+9999.0% |
DYN Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $141.24M(+3784.5%) | $542.75M(-33.0%) |
| Dec 2024 | $809.89M(+1390.9%) | $3.64M(-79.8%) | $809.89M(+0.4%) |
| Sep 2024 | - | $18.01M(-95.3%) | $806.41M(+2.2%) |
| Jun 2024 | - | $379.86M(-7.0%) | $788.85M(+81.8%) |
| Mar 2024 | - | $408.39M(>+9900.0%) | $433.89M(+698.7%) |
| Dec 2023 | $54.32M(+45.3%) | $147.00K(-67.6%) | $54.32M(-40.6%) |
| Sep 2023 | - | $454.00K(-98.2%) | $91.38M(+0.4%) |
| Jun 2023 | - | $24.91M(-13.6%) | $90.99M(+37.5%) |
| Mar 2023 | - | $28.82M(-22.5%) | $66.19M(+77.0%) |
| Dec 2022 | $37.39M | $37.20M(>+9900.0%) | $37.39M(>+9900.0%) |
| Sep 2022 | - | $70.00K(-29.3%) | $276.00K(-58.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $99.00K(+450.0%) | $663.00K(+12.6%) |
| Mar 2022 | - | $18.00K(-79.8%) | $589.00K(-99.6%) |
| Dec 2021 | $157.82M(-58.5%) | $89.00K(-80.5%) | $157.82M(+7.7%) |
| Sep 2021 | - | $457.00K(+1728.0%) | $146.54M(-72.1%) |
| Jun 2021 | - | $25.00K(-100.0%) | $526.06M(+0.0%) |
| Mar 2021 | - | $157.25M(-1504.8%) | $526.03M(+38.2%) |
| Dec 2020 | $380.69M(+1804.5%) | -$11.19M(-102.9%) | $380.69M(-2.9%) |
| Sep 2020 | - | $379.98M(>+9900.0%) | $391.88M(+3190.9%) |
| Jun 2020 | - | $0.00(-100.0%) | $11.91M(0.0%) |
| Mar 2020 | - | $11.91M | $11.91M |
| Dec 2019 | $19.99M(+60.9%) | - | - |
| Dec 2018 | $12.42M | - | - |
FAQ
- What is Dyne Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Dyne Therapeutics?
- What is Dyne Therapeutics annual CFF year-on-year change?
- What is Dyne Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly CFF year-on-year change?
- What is Dyne Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Dyne Therapeutics?
- What is Dyne Therapeutics TTM CFF year-on-year change?
What is Dyne Therapeutics annual cash flow from financing activities?
The current annual CFF of DYN is $809.89M
What is the all time high annual CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high annual cash flow from financing activities is $809.89M
What is Dyne Therapeutics annual CFF year-on-year change?
Over the past year, DYN annual cash flow from financing activities has changed by +$755.57M (+1390.92%)
What is Dyne Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of DYN is $141.24M
What is the all time high quarterly CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly cash flow from financing activities is $408.39M
What is Dyne Therapeutics quarterly CFF year-on-year change?
Over the past year, DYN quarterly cash flow from financing activities has changed by -$267.15M (-65.41%)
What is Dyne Therapeutics TTM cash flow from financing activities?
The current TTM CFF of DYN is $542.75M
What is the all time high TTM CFF for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM cash flow from financing activities is $809.89M
What is Dyne Therapeutics TTM CFF year-on-year change?
Over the past year, DYN TTM cash flow from financing activities has changed by +$108.85M (+25.09%)